Searchable abstracts of presentations at key conferences in endocrinology

ea0016p636 | Reproduction | ECE2008

Gonadotropin releasing hormone analogue in cyclophosphamide-induced premature gonadal failure prevention

Revert Paula , Moreno Oscar , Lopez-Gomez Juan Miguel , Sivera Francisca , Martinez Sandra , Perdiguero Miguel , Pascual Eliseo , Pico Antonio

Background: Premature ovarian failure (POF) due to cyclophosphamide (Cyc) therapy is well documented in systemic lupus erythematosus (SLE) patients. Studies show that the use of gonadotropin releasing hormone (GnRH) analogues appears to protect women from POF. We present our experience in SLE patients treated with triptorelin.Methods: Observational study of 15 women diagnosed of SLE who have received concomitant treatment with Cyc and GnRH analogues (tri...

ea0016p87 | Bone and calcium | ECE2008

Clinical experience with Cinacalcet for treatment of persistent primary hyperparathyroidism

Martinez-Fuster Sandra , Gonzalez Victor , Lopez Alicia , Moreno-Perez Oscar , Arias Nieves , Revert Paula , Sanchez Ruth , Boix Evangelina , Pico Antonio Miguel

Introduction: In primary hyperparathyroidism (PHPT) medical treatment is indicated if the patient donot carry out the surgical criterion, donot accept surgery or there is another serious comorbidity that makes impossible the intervention. Cinacalcet is a calcimimetic that increase the sensitivity of the calcium-sensing receptor (CaSR) to ionized serum calcium, decreasing secretion of PTH and serum calcium concentration. This drug is prescribed for secondary hyperparathyroidism...